The mortality rate for bladder malignant neoplasms in women in the US is forecasted to remain constant at 2.5 female deaths per 100,000 women from 2024 to 2028. In 2023, the mortality rate was also at 2.5. This indicates a stable trend with no year-on-year variation in the immediate forecasted period. The constant trend over the coming years suggests that no significant improvements or declines in mortality rates are expected based on current data.

Future trends to watch for:

Advancements in medical treatments and early detection technologies, which could potentially improve mortality rates.
Public health initiatives focusing on lifestyle factors and prevention strategies.
Changes in healthcare policy that could affect access to treatments.